Form 4: Anteris Technologies Director Wenyi Gu Acquires Stock Options
SEC Form 4 Filing
Director Wenyi Gu of Anteris Technologies Global Corp. was granted stock options with varying exercise prices and vesting schedules.
Summary
- Anteris Technologies Global Corp. director Wenyi Gu was granted multiple stock options on December 16, 2024.
- These options have different exercise prices, translated from AUD to USD using a rate of approximately A$1.00 to $0.64.
- The options were originally issued by Anteris Technologies Ltd (ATL) and assumed by the Issuer as part of a scheme of arrangement.
- The options vest in three equal annual installments, with different start dates depending on the specific option grant.
- A total of 170,500 options were granted across three tranches with exercise prices of $8.25, $15.28 and $14.64.
Sentiment
Score: 7
Explanation: The document reflects a standard practice of granting stock options to a director, which is generally viewed positively as it aligns interests. There are no negative implications or surprises.
Positives
- The granting of stock options to a director aligns their interests with the company's performance.
- The vesting schedule encourages long-term commitment from the director.
Industry Context
Stock option grants are a common practice for incentivizing directors and aligning their interests with shareholders in the biotechnology industry.
Comparison to Industry Standards
- Stock option grants are a standard form of compensation for directors in publicly listed companies, particularly in the biotech sector.
- The vesting schedules are typical, designed to encourage long-term commitment and performance.
- The exercise prices are set at a premium to the current share price, which is common practice.
Stakeholder Impact
- The granting of stock options to a director can be viewed positively by shareholders as it aligns management's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 12/16/2024 | Date of the stock option grants and effective date of the scheme of arrangement. |
| 12/18/2024 | Date of the filing of the SEC Form 4. |
| 12/31/2022 | First vesting date for the first tranche of options. |
| 09/15/2024 | First vesting date for the second tranche of options. |
| 06/19/2025 | First vesting date for the third tranche of options. |
| 06/13/2027 | Expiration date for the first tranche of options. |
| 09/15/2028 | Expiration date for the second tranche of options. |
| 06/19/2029 | Expiration date for the third tranche of options. |
Keywords
stock options, director, Anteris Technologies, equity, vesting, compensation, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.